Government

Image description

Panelists at NACDS TSE examine in-store testing

With diabetes and other diseases at epidemic levels, the need for more pharmacies to step up and offer accessible, convenient patient screening for a variety of serious and even life-threatening conditions is clear, a panel of pharmacists asserted at the NACDS Total Store Expo “Convenient Care — Point of Care Testing in the Pharmacy” Insight Session in late August. So, too, is the opportunity to drive new business to the pharmacy through point-of-care testing services.

Image description

Diabetic treatment key for Star ratings

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

Image description

FDA expands approval for Xtandi caps

Medivation and Astellas Pharma on Wednesday announced that the Food and Drug Administration approved a new use of Xtandi (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer.

Image description

NACDS-backed provider status bill hits milestone

The National Association of Chain Drug Stores has announced that NACDS-backed bipartisan legislation, H.R. 4190, which would expand pharmacists’ ability to serve patients and improve their healthcare outcomes, has garnered a milestone 100 co-sponsors.

Image description

FDA approves two new indications for Epaned

Silvergate Pharmaceuticals on Monday announced that the Food and Drug Administration approved Epaned (enalapril maleate Powder for oral solution) for the treatment of symptomatic heart failure, as well as the treatment of asymptomatic left ventricular dysfunction.